# Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.

> **NCT04148183** · PHASE2,PHASE3 · COMPLETED · sponsor: **J JESUS VENEGAS, MD** · enrollment: 30 (actual)

## Conditions studied

- Insulin Resistance

## Interventions

- **DRUG:** Metformin group
- **DRUG:** Rosiglitazone group
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04148183
- **Lead sponsor:** J JESUS VENEGAS, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01-01
- **Primary completion:** 2005-01-01
- **Final completion:** 2009-01-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-11-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04148183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04148183, "Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04148183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*